Coordinate regulation of ELF5 and EHF at the chr11p13 CF modifier region.
Hannah SwahnJey Sabith EbronKay-Marie LamarShiyi YinJenny L KerschnerMonali NandyMazumdarCandice CoppolaEric M MendenhallShih-Hsing LeirAnn HarrisPublished in: Journal of cellular and molecular medicine (2019)
E74-like factor 5 (ELF5) and ETS-homologous factor (EHF) are epithelial selective ETS family transcription factors (TFs) encoded by genes at chr11p13, a region associated with cystic fibrosis (CF) lung disease severity. EHF controls many key processes in lung epithelial function so its regulatory mechanisms are important. Using CRISPR/Cas9 technology, we removed three key cis-regulatory elements (CREs) from the chr11p13 region and also activated multiple open chromatin sites with CRISPRa in airway epithelial cells. Deletion of the CREs caused subtle changes in chromatin architecture and site-specific increases in EHF and ELF5. CRISPRa had most effect on ELF5 transcription. ELF5 levels are low in airway cells but higher in LNCaP (prostate) and T47D (breast) cancer cells. ATAC-seq in these lines revealed novel peaks of open chromatin at the 5' end of chr11p13 associated with an expressed ELF5 gene. Furthermore, 4C-seq assays identified direct interactions between the active ELF5 promoter and sites within the EHF locus, suggesting coordinate regulation between these TFs. ChIP-seq for ELF5 in T47D cells revealed ELF5 occupancy within EHF introns 1 and 6, and siRNA-mediated depletion of ELF5 enhanced EHF expression. These results define a new role for ELF5 in lung epithelial biology.
Keyphrases
- transcription factor
- genome wide
- single cell
- dna damage
- gene expression
- crispr cas
- induced apoptosis
- dna methylation
- prostate cancer
- cystic fibrosis
- genome wide identification
- minimally invasive
- poor prognosis
- dna binding
- signaling pathway
- binding protein
- cell death
- long non coding rna
- endoplasmic reticulum stress
- genome wide association study